期刊文献+

冠状动脉造影数字跟踪技术测定心脏X综合征患者冠状动脉血流储备的临床观察 被引量:3

Clinical observation of coronary flow reserve in patients with cardiac syndrome X by tracking digital angiography
下载PDF
导出
摘要 目的通过常规冠状动脉造影,运用数字跟踪技术软件测定心脏X综合征患者冠状动脉血流储备(coronary flow reserve,CFR),探讨其变化意义。方法 98例拟诊冠状动脉粥样硬化性心脏病(冠心病)患者,其中心脏X综合征患者62例,对照组36例。冠状动脉造影同时运用数字跟踪技术软件测算CFR,抽血检测血清高敏C反应蛋白(high-sensitivity C-reactive protein,hsCRP)浓度,利用统计软件比较两组检测结果。结果 X综合征组患者CFR低于对照组,差异有统计学意义(P<0.05);血清hsCRP浓度高于对照组,差异有统计学意义(P<0.01)。结论 X综合征患者存在CFR降低及血清hsCRP浓度升高,提示CFR降低及炎症反应可能是其临床症状的病理生理基础。 Objectives To investigate and evaluate the change of coronary flow reserve (CFR) in patients with cardiac syndrome X by tracking digital angiography. Methods Ninty-eight cases with suspected coronary artery disease underwent coronary angiography. Of them, CFR of 62 cases with cardiac syndrome X and 36 matched healthy subjects were measured by tracking digital angiography, and serum concentrations of high-sensitivity C-reactive protein (hsCRP) were detected. The change of CFR and hsCRP were observed and analyzed between the two groups. Results CFR in group of cardiac syndrome X was significantly lower than that of match group (P〈0.05), while hsCRP was significantly higher (P〈O.01). Conclusions CFR in cardiac syndrome X group is lower than that of healthy subjects, while hsCRP is higher. This indicates that lower flow reserve and inflammation can play a key role in the pathophysiological mechanism for patients with cardiac syndrome X.
出处 《岭南心血管病杂志》 2013年第6期704-706,共3页 South China Journal of Cardiovascular Diseases
基金 江苏省徐州市科技局课题资助(项目编号:X200523107)
关键词 冠状动脉疾病 心脏X综合征 冠状动脉血流储备 冠状动脉造影数字跟踪技术 高敏C反应蛋白 coronary artery disease cardiac syndrome X coronary flow reserve tracking digital angiography high- sensitivity C-reactive protein
  • 相关文献

参考文献17

  • 1LANZA G A. Cardiac syndrome X: a critical overview and future perspectives[J]. Heart,2007, 93(2): 159-166.
  • 2DOMINGUEZ RODRIGUEZ A, GARCIA GONZALEZ M, ABREU GONZALEZ P. Cardiac syndrome X: diagnosis, pathogenesis and management [ J . Am J Cardiovasc Drugs, 2004, 4( ) : 423-424.
  • 3LANZA G A, SESTITO A, CAMMAROTA G, et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X [J]. Am J Cardiol, 2004, 94 ( 1 ) : 40-44.
  • 4TOMAI F. C reactive protein and mierovaseular function [J]. Heart, 2004, 90(7): 727-728.
  • 5LI J J, ZHENG X, ZHANG C Y, et al. Xuezhikang, an extraet of eholestin, decreases plasma inflammatory markers and endothelin- 1 ,improve exercise-induced isehemia and subjective feelings in patients with cardiae syndrome X [Jl. Int J Cardiol, 2007, 122 (1): 82-84.
  • 6ARROYO ESPLIGUERO R, MOLLICHELLI N, AVANZAS P, et al. Chronic inflammation and increased.
  • 7arterial stiffness in patients with cardiac syndrome X[J]. Eur Heart J, 2003, 24(22) : 2006-2011. ROSENSON R S. Statin therapy:new therapy for cardiac mierovaseular dysfunction [J]. Eur Heart J, 2003, 24 (22): 1993-1994.endothelial progenitor ceils in patients with cardiac syndrome X[J]. Heart, 2007, 93(9) : 1064-1070.
  • 8HUANG P H, CHEN Y H, CHEN Y L, et al. Vascular endothelial function and circulating.
  • 9王贤良,毛静远,王恒和.心脏X综合征与相关细胞因子研究进展[J].中国心血管病研究,2007,5(5):372-374. 被引量:14
  • 10VRUBLEVSKY A V, BOSHCHENKO A A, KARPOV R S. Reduced coronary flow reserve in the coronary sinus is a predictor of hemodynamically significant stenoses of the left coronary artery territory[J1. EurJ Echocardiogr, 2004, 5(4): 294-303.

二级参考文献42

共引文献22

同被引文献25

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部